Company
Tellus Therapeutics
Transforming Care Within and Beyond the NICU
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Founded
- 2018
- tellustherapeutics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Tellus Therapeutics is developing first-in-class treatments for newborns at risk for brain injury, and is advancing global standards of neonatal care.
Funding snapshot
- Total raised
- $35MSum of rounds, as of 2026-09-20Source (opens in a new tab)
- Latest round
- Series A, $35M2022-12-13
Funding rounds
- Series A
- $35M2022-12-13, Company stated
- Round, 2022
- $16M2022-11-17, SEC form D sold, 1 investor
- Seed
- 2021-05-12
- Round, 2021
- $2M2021-05-10, SEC form D sold, 1 investor
- Grant
- 2020-12-08
- Round, 2019
- $75K2019-01-21, SEC form D sold, 1 investor
Products
- Other
- TT-20
Loading relationship preview